InvestorsHub Logo

JRoon71

08/23/23 11:56 AM

#414488 RE: sts66 #414484

STS, if it proves to be efficacious (which it has in animal trials), then I think they are selling it to a BP based on the opportunity.

I don't have any illusions that Amarin will ever sell this formulation to patients. This is a carrot to dangle in front of a BP.

If they DO plan to get this thing to market before selling to BP, then we are in for a LONG road.